FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Most people hear not FDA approved and immediately think unsafe or ineffective but the reality is a lot more about economics than science. If something can't be patented, there's little incentive to FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC